Director, Epidemiology
CurrentDesigning and implementing methodologically rigorous pharmacoepidemiology studies satisfying post-marketing regulatory commitments or generating needed real-world evidence (RWE) in numerous therapeutic areas and in a variety of diverse health settings. Experiences include: designing post-authorization safety studies (PASS) and real-world evidence (RWE) studies; producing protocols, statistical analysis plans, and reports for submission to regulatory agencies; support of large, multidisciplinary teams in implementing multi-national and multi-database studies; interpreting and synthesizing evidence from multiple sources; methodological consulting for numerous practice areas.
Dec 2021 - Present
